Post Hematopoietic Stem Cell Transplantation

Clinical trial NCT01610297 · COMPLETED

Trial details

NCT number: NCT01610297
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major

Start date: 2013-09-01
Primary completion: 2015-10-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.